JPH09512523A - 肺血管収縮及び喘息を治療する方法 - Google Patents
肺血管収縮及び喘息を治療する方法Info
- Publication number
- JPH09512523A JPH09512523A JP7525910A JP52591095A JPH09512523A JP H09512523 A JPH09512523 A JP H09512523A JP 7525910 A JP7525910 A JP 7525910A JP 52591095 A JP52591095 A JP 52591095A JP H09512523 A JPH09512523 A JP H09512523A
- Authority
- JP
- Japan
- Prior art keywords
- gas
- inhibitor
- mammal
- pulmonary
- inhalation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0086—Inhalation chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0266—Nitrogen (N)
- A61M2202/0275—Nitric oxide [NO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.哺乳動物における可逆的な肺血管収縮を治療又は予防する方法であって、該 治療又は予防の必要な哺乳動物を同定し、治療に効果的な量のガス状の一酸化窒 素を哺乳動物に吸入させ、さらに該吸入段階の前、最中、又は直後に治療に効果 的な量のホスホジエステラーゼ阻害剤を該哺乳動物に吸入させることを含む方法 。 2.肺血管収縮が急性肺血管収縮である、請求の範囲1に記載の方法。 3.哺乳動物が、肺炎、外傷、呼吸又は吸入障害、肺の脂肪塞栓症、アシドーシ ス、肺の炎症、成人呼吸促進症候群、急性高山病、心臓手術後の急性肺高血圧症 、新生児持続性肺高血圧、周産期吸引症候群、ヒアリン膜症、急性肺血栓塞栓症 、急性肺水腫、ヘパリン−プロタミン反応、敗血症、低酸素症、喘息、および喘 息発作重積状態からなる群から選ばれる臨床状態にあるか、それを発症する危険 を有する場合の、請求の範囲1に記載の方法。 4.肺血管収縮が可逆的な要素を有する慢性の肺血管収縮である、請求の範囲1 に記載の方法。 5.哺乳動物が、慢性肺高血圧症、気管支肺形成不全、慢性肺血栓塞栓症、特発 性肺高血圧症、および慢性低酸素症からなる群より選ばれる臨床状態にあるか、 それを発症する危険にある、請求の範囲1に記載の方法。 6.一酸化窒素が予め決定された濃度範囲で少なくとも3分間吸入される、請求 の範囲1に記載の方法。 7.濃度が少なくとも0.01 ppmである、請求の範囲1に記載の方法。 8.濃度が少なくとも0.5 ppmである、請求の範囲1に記載の方法。 9.濃度が少なくとも5 ppmである、請求の範囲1に記載の方法。 10.阻害剤がサイクリックGMP特異的ホスホジエステラーゼを選択する、請求 の範囲1に記載の方法。 11.阻害剤が、ザプリナスト(Zaprinast)である、請求の範囲1に記載の方 法。 12.阻害剤が口腔、静脈内、筋肉内、皮下、または腹腔内の経路により哺乳動 物に導入される、請求の範囲1に記載の方法。 13.阻害剤が、該阻害剤を含むエアロゾルまたは乾燥粉末を哺乳動物に吸入さ せることにより哺乳動物に導入される、請求の範囲1に記載の方法。 14.阻害剤がガス状の一酸化窒素を含むガスとともに吸入される、請求の範囲 13に記載の方法。 15.哺乳動物がヒトである、請求の範囲1に記載の方法。 16.哺乳動物における肺血管収縮を治療又は予防する方法であって、治療に効 果的な量の一酸化窒素放出化合物およびホスホジエステラーゼ阻害剤を哺乳動物 に吸入させることを含む方法。 17.ホスホジエステラーゼ阻害剤がサイクリックGMP特異的ホスホジエステラ ーゼ阻害剤である、請求の範囲16に記載の方法。 18.哺乳動物における気管支収縮を治療又は予防する方法であって、該治療又 は予防の必要な哺乳動物を同定し、治療に効果的な量のガス状の一酸化窒素を哺 乳動物に吸入させ、さらに該吸入段階の前、最中、又は直後に治療に効果的な量 のホスホジエステラーゼ阻害剤を該哺乳動物に吸入させることを含む方法。 19.哺乳動物がヒトである、請求の範囲18に記載の方法。 20.ホスホジエステラーゼ阻害剤がサイクリックGMP特異的ホスホジエステラ ーゼを選択的に阻害する、請求の範囲18に記載の方法。 21.ホスホジエステラーゼ阻害剤がザプリナスト(Zaprinast)である、請求 の範囲20に記載の方法。 22.阻害剤が口腔、静脈内、筋肉内、皮下、または腹腔内の経路により哺乳動 物に導入される、請求の範囲18に記載の方法。 23.阻害剤が、該阻害剤を含むエアロゾルまたは乾燥粉末を哺乳動物に吸入さ せることにより哺乳動物に導入される、請求の範囲18に記載の方法。 24.阻害剤が一酸化窒素を含むガス混合物とともに吸入される、請求の範囲2 3に記載の方法。 25.気管支収縮が喘息に関連している、請求の範囲18に記載の方法。 26.哺乳動物の肺におけるガス交換を改善する方法であって、治療に効果的な 量のガス状の一酸化窒素を哺乳動物に吸入させ、さらに該吸入段階の前、最中、 又は直後に治療に効果的な量のホスホジエステラーゼ阻害剤を該哺乳動物に導入 することを含む方法。 27.哺乳動物が低酸素血症である、請求の範囲26に記載の方法。 28.哺乳動物が肺傷害を受けている、請求の範囲26に記載の方法。 29.ホスホジエステラーゼ阻害剤を哺乳動物の肺に輸送する方法であって、該 哺乳動物に一酸化窒素を含むガスに懸濁した該化合物を吸入させることを含む方 法。 30.(a)ホスホジエステラーゼ阻害剤を含む小室、および(b)該小室に連 結しているルーメンを区切る外枠、0.1 ppm以上の一酸化窒素を含む圧縮ガスを 含む容器であって、該小室に該ガスを制御しつつ放出する機構を有し、これによ り該阻害剤を放出されたガスに懸濁する容器、また、患者の呼吸器系に該放出ガ スを導くように形成されているルーメンで規定される外枠を含む吸入器。 31.阻害剤がサイクリックGMP特異的ホスホジエステラーゼを選択する、請求 の範囲30に記載の装置。 32.阻害剤がザプリナスト(Zaprinast)である、請求の範囲31に記載の装 置。 33.容器が、小室を迂回しながら、ガスをルーメンに制御しつつ放出する機構 をも有する、請求の範囲30に記載の装置。 34.圧縮ガス、または液化高圧ガスに懸濁したホスホジエステラーゼ阻害剤化 合物を含む容器、(a)該容器が上に取り付けられているポートおよび(b)該 ポートと連結しているルーメンで区切っている外枠、および該容器から該ルーメ ンに高圧ガスを制御しつつ放出する機構であり、これにより該懸濁化合物を該容 器から該ルーメンに放出する機構を含む装置であって、該ルーメンが放出された 高圧ガスに懸濁した該化合物をヒトの呼吸器系に導くように配置された装置。 35.化合物が粉末状である、請求の範囲34に記載の装置。 36.化合物が生物学的に許容される液体担体に溶解または懸濁されている、請 求の範囲34に記載の装置。 37.圧縮ガス、または液化高圧ガスを含む容器、(a)ホスホジエステラーゼ 阻害剤化合物を含む小室、および(b)該小室に連結しているルーメンを区切っ ている外枠、該容器から該小室にガスを制御しつつ放出する機構であり、これに より該化合物をガスに懸濁する機構を含む装置であって、該ルーメンが該化合物 をヒトの呼吸器系に導くように配置された装置。 38.ガスが一酸化窒素ガスを含む、請求の範囲37に記載の装置。 39.ホスホジエステラーゼ阻害剤が、WIN 58237(1-シクロペンチル-3-メチル -6-(4-ピリジル)ピラゾロ[3,4-d]ピリミジン-4-(5H)-オン)、SCH 48936((+)-6 a,7,8,9a,10,11a-オクタヒドロ-2,5-ジメチル-3Hペンタレン(6a,1,4,5)イミダゾ [2,1-b]プリン-4(5H)-オン)、KT2-734(2-フェニル-8-エトキシシクロヘプトイ ミダゾール)、およびE4021(ソディウム1-[6-クロロ-4-(3,4-メチレンジオキシ ベンジル)-アミノキナゾリン-2-y]ピペリジン-4-カルボキシレート セスキハイ ドレート)からなる群より選ばれる、請求の範囲20に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/222,256 | 1994-04-01 | ||
US08/222,256 US5570683A (en) | 1990-12-05 | 1994-04-01 | Methods and devices for treating pulmonary vasoconstriction and asthma |
PCT/US1995/004123 WO1995026768A1 (en) | 1994-04-01 | 1995-04-03 | Methods for treating pulmonary vasoconstriction and asthma |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09512523A true JPH09512523A (ja) | 1997-12-16 |
Family
ID=22831508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7525910A Pending JPH09512523A (ja) | 1994-04-01 | 1995-04-03 | 肺血管収縮及び喘息を治療する方法 |
Country Status (11)
Country | Link |
---|---|
US (1) | US5570683A (ja) |
EP (2) | EP0754069B1 (ja) |
JP (1) | JPH09512523A (ja) |
KR (1) | KR100371082B1 (ja) |
AT (2) | ATE316396T1 (ja) |
AU (1) | AU688027B2 (ja) |
CA (1) | CA2186892C (ja) |
DE (2) | DE69533190T2 (ja) |
DK (2) | DK0754069T3 (ja) |
ES (2) | ES2224123T3 (ja) |
WO (1) | WO1995026768A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005504001A (ja) * | 2001-02-14 | 2005-02-10 | デューク・ユニバーシティ | Gsnoの充足を起こすガス状薬剤による肺疾患の処置 |
JP2010509353A (ja) * | 2006-11-07 | 2010-03-25 | ザ ジェネラル ホスピタル コーポレイション | 血管作動性酸素運搬体に誘導される血管収縮の減弱 |
JP2012092129A (ja) * | 2003-07-09 | 2012-05-17 | Government Of The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | 亜硝酸塩によって特定の心臓血管状態を処置する方法 |
JP2014532764A (ja) * | 2011-11-07 | 2014-12-08 | ザ ジェネラル ホスピタル コーポレイション | 赤血球の処理法 |
JP2014240443A (ja) * | 2003-06-27 | 2014-12-25 | マイラン スペシャルティ エルピー | 肺高血圧治療のための吸入可能製剤およびその使用方法 |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6250300B1 (en) * | 1992-12-11 | 2001-06-26 | Ab Astra | System for dispensing pharmaceutically active compounds |
GB9320978D0 (en) * | 1993-10-12 | 1993-12-01 | Higenbottam Timohy W | Nitric oxide treatment |
US6063407A (en) * | 1995-02-16 | 2000-05-16 | The General Hospital Corporation | Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
US5823180A (en) * | 1995-04-03 | 1998-10-20 | The General Hospital Corporation | Methods for treating pulmonary vasoconstriction and asthma |
US5703073A (en) | 1995-04-19 | 1997-12-30 | Nitromed, Inc. | Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
IT1282686B1 (it) | 1996-02-26 | 1998-03-31 | Nicox Sa | Composti in grado di ridurre la tossicita' da farmaci |
US5699790A (en) * | 1996-03-21 | 1997-12-23 | Ohmeda Inc. | System for predicting NO2 concentrations |
US5824669A (en) * | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
US5765548A (en) * | 1996-05-07 | 1998-06-16 | Perry; Bryan J. | Use of nitric oxide in the treatment of exercised induced pulmonary hemorrhaging in equine |
US5958926A (en) | 1996-11-01 | 1999-09-28 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
USRE37234E1 (en) | 1996-11-01 | 2001-06-19 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
US6027713A (en) * | 1997-03-06 | 2000-02-22 | Meri Charmyne Russell | Composition and method for the treatment of exercise induced pulmonary hemorrhage |
CA2225013C (en) | 1997-04-04 | 2006-06-06 | Institut Du N.O. Inc. | Injection system for delivery of a gaseous substance |
US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
US5998386A (en) * | 1997-09-19 | 1999-12-07 | Feldman; Arthur M. | Pharmaceutical compositions and method of using same for the treatment of failing myocardial tissue |
AU9596698A (en) * | 1997-10-15 | 1999-05-03 | Thomas Jefferson University | Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
US6656452B1 (en) * | 1997-10-21 | 2003-12-02 | The General Hospital Corporation | Use of inhaled NO as anti-inflammatory agent |
US6472425B1 (en) | 1997-10-31 | 2002-10-29 | Nitromed, Inc. | Methods for treating female sexual dysfunctions |
US6109260A (en) * | 1998-02-18 | 2000-08-29 | Datex-Ohmeda, Inc. | Nitric oxide administration device with timed pulse |
US20070275100A1 (en) * | 1998-11-23 | 2007-11-29 | Miller Christopher C | Use of gaseous nitric oxide as an anti-cancer agent |
FR2795644B1 (fr) * | 1999-07-02 | 2004-07-30 | Air Liquide Sante Int | Utilisations therapeutiques d'un melange helium/oxygene, en particulier dans le traitement de l'asthme |
US7017573B1 (en) * | 1999-07-12 | 2006-03-28 | Capnia, Incorporated | Methods and apparatus for relieving headaches, rhinitis and other common ailments |
US6314956B1 (en) * | 1999-09-08 | 2001-11-13 | Duke University | Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders |
US6694969B1 (en) * | 1999-09-22 | 2004-02-24 | Instrumentarium Corp. | Method to improve oxygenation in subjects suffering impaired oxygenation |
TW200400821A (en) * | 1999-11-02 | 2004-01-16 | Pfizer | Pharmaceutical composition (II) useful for treating or preventing pulmonary hypertension in a patient |
US20060172017A1 (en) * | 1999-11-08 | 2006-08-03 | Capnia, Incorporated | Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces |
US20070039615A1 (en) * | 1999-11-08 | 2007-02-22 | Capnia, Incorporated | Methods and apparatus for treating rhinitis |
JP2004500168A (ja) * | 1999-11-08 | 2004-01-08 | キャプニア インコーポレイテッド | ガスと薬剤とを共投与して両者の相乗効果で頭痛やアンギナ及び他の症状を軽減するための方法及び装置 |
US7516742B2 (en) | 1999-11-24 | 2009-04-14 | Cardinal Health 207, Inc. | Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing |
US8251070B2 (en) * | 2000-03-27 | 2012-08-28 | Asthmatx, Inc. | Methods for treating airways |
GB0014898D0 (en) * | 2000-06-19 | 2000-08-09 | Innovata Biomed Ltd | Delivery system |
US6601580B1 (en) * | 2000-06-28 | 2003-08-05 | The General Hospital Corporation | Enhancing therapeutic effectiveness of nitric oxide inhalation |
KR20030065463A (ko) | 2000-08-11 | 2003-08-06 | 데이비드 알. 휘트록 | 질소 산화물 및 질소 산화물 전구체의 생산을 증가시키기위한 암모니아 산화 박테리아를 포함하는 조성물 및 이를이용하는 방법 |
US7122018B2 (en) | 2000-12-26 | 2006-10-17 | Sensormedics Corporation | Device and method for treatment of wounds with nitric oxide |
US7335181B2 (en) * | 2000-12-26 | 2008-02-26 | Pulmonox Technologies Corporation | Nitric oxide decontamination of the upper respiratory tract |
US6432077B1 (en) | 2000-12-26 | 2002-08-13 | Sensormedics Corporation | Device and method for treatment of surface infections with nitric oxide |
KR20040032115A (ko) | 2001-06-21 | 2004-04-14 | 베쓰 이스라엘 디코니스 메디칼 센터 인크 | 조직 및 장기 이식 결과의 개선 및 아폽토시스의 억제에사용되는 일산화탄소 |
US7432301B2 (en) * | 2001-08-20 | 2008-10-07 | University Of Virginia Patent Foundation | Use of S-nitrosothiol signaling to treat disordered control of breathing |
EP2565157B1 (en) * | 2001-09-05 | 2017-10-04 | Geno LLC | Nitric oxide generation |
US20030070674A1 (en) * | 2001-10-12 | 2003-04-17 | Bryan Perry | Use of aerosolized compounds in the treatment of exercise induced pulmonary hemorrhage in an equine |
GB0125222D0 (en) * | 2001-10-19 | 2001-12-12 | Barts & London Nhs Trust | Composition for the treatment of microbial infections |
EP1472021A4 (en) * | 2002-01-11 | 2008-04-16 | David R Whitlock | AMMONIAX OXIDIZING BACTERIA CONTAINING COMPOSITIONS AND USER METHOD THEREFOR |
US20030170223A1 (en) * | 2002-02-01 | 2003-09-11 | Board Of Trustees Of Michigan State University | Pulmonary vasodilator surfactant compositions and method of use |
MXPA04012863A (es) * | 2002-06-21 | 2005-03-31 | Univ Pittsburgh | Uso farmaceutico de oxido nitrico, heme oxigenasa-1 y productos de degradacion de heme. |
EP1558312B1 (en) * | 2002-06-28 | 2017-08-09 | The Research Foundation of the State University of New York | Therapeutic agent delivery device and method |
US7531133B2 (en) | 2002-09-10 | 2009-05-12 | Pulmonox Technologies Corporation | Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma |
WO2005077005A2 (en) * | 2004-02-04 | 2005-08-25 | The General Hospital Corporation | Enhancing the effectiveness of an inhaled therapeutic gas |
CA2619590A1 (en) * | 2004-04-01 | 2004-08-08 | Methapharm Inc. | Solution based methacholine formulations |
US20050222267A1 (en) * | 2004-04-01 | 2005-10-06 | Truong Van H | Solution based methacholine formulations |
EP1755715A4 (en) | 2004-05-11 | 2010-03-24 | Sensormedics Corp | INTERMITTENT DETERMINATION OF GASEOUS NITRIC OXIDE |
US8518457B2 (en) | 2004-05-11 | 2013-08-27 | Pulmonox Technologies Corporation | Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant |
US7362274B1 (en) * | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
US7560076B2 (en) | 2004-08-18 | 2009-07-14 | Geno Llc | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
US7618594B2 (en) | 2004-08-18 | 2009-11-17 | Geno Llc | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
WO2006125123A2 (en) * | 2005-05-19 | 2006-11-23 | University Of Cincinnati | Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite |
US8079998B2 (en) | 2006-10-20 | 2011-12-20 | Pulmonox Technologies Corporation | Methods and devices for the delivery of therapeutic gases including nitric oxide |
US7947227B2 (en) * | 2007-03-23 | 2011-05-24 | Geno Llc | Kit for the conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
WO2009086470A2 (en) * | 2007-12-27 | 2009-07-09 | Aires Pharmaceuticals, Inc. | Aerosolized nitrite and nitric oxide - donating compounds and uses thereof |
EP2247381B1 (en) | 2008-01-28 | 2016-11-30 | Geno LLC | Conversion of nitrogen dioxide (no2) to nitric oxide (no) |
US8607785B2 (en) | 2008-08-21 | 2013-12-17 | Geno Llc | Systems and devices for generating nitric oxide |
US10960168B2 (en) * | 2008-08-21 | 2021-03-30 | Vero Biotech LLC | Delivery of high concentration nitric oxide |
US8613958B2 (en) | 2009-06-22 | 2013-12-24 | Geno Llc | Nitric oxide therapies |
CA2671029A1 (en) * | 2009-06-30 | 2010-12-30 | James S. Baldassarre | Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension |
WO2011063335A1 (en) * | 2009-11-20 | 2011-05-26 | Geno Llc | Nitric oxide delivery system |
US8685467B2 (en) * | 2010-08-03 | 2014-04-01 | J. W. Randolph Miller | Nitric oxide generation, dilution, and topical application apparatus and method |
US20120107423A1 (en) | 2010-11-01 | 2012-05-03 | Ino Therapeutics Llc | Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome |
US10517817B2 (en) | 2013-05-09 | 2019-12-31 | Syk Technologies, Llc | Deep topical systemic nitric oxide therapy apparatus and method |
CN106456666A (zh) | 2014-01-10 | 2017-02-22 | Ino治疗有限责任公司 | 使用吸入性一氧化氮气体来治疗儿童的急性呼吸窘迫综合征的方法 |
US11225640B2 (en) | 2014-04-15 | 2022-01-18 | Aobiome Llc | Ammonia oxidizing bacteria for treatment of psoriasis |
CN106456678A (zh) | 2014-04-15 | 2017-02-22 | Ao生物医学有限责任公司 | 氨氧化型亚硝化单胞菌菌株d23 |
JP6480598B2 (ja) | 2015-04-02 | 2019-03-13 | ヒル−ロム サービシーズ プライヴェート リミテッド | 呼吸装置用マニホールド |
EP3432954B1 (en) * | 2016-03-24 | 2022-04-20 | Services Medicaux Arnold et Joan Zidulka Inc. | Device for delivering particles in the upper respiratory tract |
TW201907934A (zh) * | 2017-07-18 | 2019-03-01 | 美商微辰生命有限公司 | 用於治療肺動脈高血壓之氨氧化微生物 |
KR102106221B1 (ko) | 2018-10-13 | 2020-04-29 | 이용운 | 지열을 이용한 수도미터기 보호통 |
EP3911393A4 (en) * | 2019-01-14 | 2022-10-19 | Bellerophon Therapeutics | COMBINATION THERAPIES OF PDE-5 INHIBITORS AND INHALED NITROUS OXIDE |
KR102292942B1 (ko) | 2019-09-11 | 2021-08-23 | 이용운 | 지열을 이용한 수도미터기 보호통 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3785377A (en) * | 1970-11-12 | 1974-01-15 | S Jorgensen | Plant, preferably for anaesthesia |
US4010897A (en) * | 1976-03-31 | 1977-03-08 | Charles F. Kettering Foundation | Method and apparatus for home production and application of nitrogen fertilizer |
IL57239A (en) * | 1979-05-08 | 1982-04-30 | Alamaro Moshe | Production of nitric oxides |
US4297123A (en) * | 1980-02-07 | 1981-10-27 | Wyse Harold G | Method and apparatus for producing a nitrate fertilizer |
US4336798A (en) * | 1980-10-06 | 1982-06-29 | Anthony V. Beran | Medical corrugated respiratory tube |
SE438261B (sv) * | 1981-07-08 | 1985-04-15 | Draco Ab | Anvendning i dosinhalator av ett perforerat membran |
US4534343A (en) * | 1984-01-27 | 1985-08-13 | Trutek Research, Inc. | Metered dose inhaler |
US4592348A (en) * | 1984-12-17 | 1986-06-03 | Waters Iv William C | Aerosol inhaler |
US4852561A (en) * | 1988-07-27 | 1989-08-01 | Sperry C R | Inhalation device |
US4877589A (en) * | 1988-09-19 | 1989-10-31 | Hare Louis R O | Nitrogen fixation by electric arc and catalyst |
US4915915A (en) * | 1988-10-11 | 1990-04-10 | Treharne Richard W | Water-powdered piezoelectric unit for producing nitrogen fertilizer |
US4954526A (en) * | 1989-02-28 | 1990-09-04 | The United States Of America As Represented By The Department Of Health And Human Services | Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents |
US5208233A (en) * | 1989-09-15 | 1993-05-04 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
US5260210A (en) * | 1989-09-27 | 1993-11-09 | Rubin Lee L | Blood-brain barrier model |
US5178138A (en) * | 1990-09-11 | 1993-01-12 | Walstrom Dennis R | Drug delivery device |
US5155137A (en) * | 1990-09-20 | 1992-10-13 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Complexes of nitric oxide with polyamines |
DE122008000012I2 (de) * | 1990-12-05 | 2012-04-12 | Gen Hospital Corp | Vorrichtung zum Behandeln einen Lungengefassverengung und von Asthma. |
US5396882A (en) * | 1992-03-11 | 1995-03-14 | The General Hospital Corporation | Generation of nitric oxide from air for medical uses |
IL101406A (en) * | 1991-03-29 | 1998-02-08 | Brigham & Womens Hospital | Pharmaceutical compositions containing s-nitrosothiol derivatives |
WO1993012068A1 (en) * | 1991-12-11 | 1993-06-24 | Brigham And Women's Hospital | S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof |
US5246970A (en) * | 1991-12-16 | 1993-09-21 | Washington University | Method of inhibiting nitric oxide formation |
US5427797A (en) * | 1993-04-06 | 1995-06-27 | Brigham And Women's Hospital | Systemic effects of nitric oxide inhalation |
-
1994
- 1994-04-01 US US08/222,256 patent/US5570683A/en not_active Expired - Lifetime
-
1995
- 1995-04-03 AU AU22058/95A patent/AU688027B2/en not_active Ceased
- 1995-04-03 DK DK95915014T patent/DK0754069T3/da active
- 1995-04-03 DK DK04013974T patent/DK1466641T3/da active
- 1995-04-03 EP EP95915014A patent/EP0754069B1/en not_active Expired - Lifetime
- 1995-04-03 JP JP7525910A patent/JPH09512523A/ja active Pending
- 1995-04-03 CA CA002186892A patent/CA2186892C/en not_active Expired - Fee Related
- 1995-04-03 EP EP04013974A patent/EP1466641B1/en not_active Expired - Lifetime
- 1995-04-03 AT AT04013974T patent/ATE316396T1/de active
- 1995-04-03 ES ES95915014T patent/ES2224123T3/es not_active Expired - Lifetime
- 1995-04-03 DE DE69533190T patent/DE69533190T2/de not_active Expired - Lifetime
- 1995-04-03 WO PCT/US1995/004123 patent/WO1995026768A1/en active Search and Examination
- 1995-04-03 AT AT95915014T patent/ATE269731T1/de active
- 1995-04-03 DE DE69534755T patent/DE69534755T2/de not_active Expired - Lifetime
- 1995-04-03 KR KR1019960705567A patent/KR100371082B1/ko not_active IP Right Cessation
- 1995-04-03 ES ES04013974T patent/ES2255020T3/es not_active Expired - Lifetime
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005504001A (ja) * | 2001-02-14 | 2005-02-10 | デューク・ユニバーシティ | Gsnoの充足を起こすガス状薬剤による肺疾患の処置 |
JP4652664B2 (ja) * | 2001-02-14 | 2011-03-16 | デューク ユニバーシティ | Gsnoの充足を起こすガス状薬剤による肺疾患の処置 |
JP2014240443A (ja) * | 2003-06-27 | 2014-12-25 | マイラン スペシャルティ エルピー | 肺高血圧治療のための吸入可能製剤およびその使用方法 |
US9498437B2 (en) | 2003-06-27 | 2016-11-22 | Mylan Specialty L.P. | Inhalable formulations for treating pulmonary hypertension and methods of using same |
JP2012092129A (ja) * | 2003-07-09 | 2012-05-17 | Government Of The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | 亜硝酸塩によって特定の心臓血管状態を処置する方法 |
US8927030B2 (en) | 2003-07-09 | 2015-01-06 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of nitrite salts for the treatment of cardiovascular conditions |
US9387224B2 (en) | 2003-07-09 | 2016-07-12 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Treatment of specific cardiovascular conditions with nitrite |
US9675637B2 (en) | 2003-07-09 | 2017-06-13 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of nitrite salts for the treatment of cardiovascular conditions |
US9700578B2 (en) | 2003-07-09 | 2017-07-11 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of nitrite salts for the treatment of cardiovascular conditions |
JP2010509353A (ja) * | 2006-11-07 | 2010-03-25 | ザ ジェネラル ホスピタル コーポレイション | 血管作動性酸素運搬体に誘導される血管収縮の減弱 |
JP2014532764A (ja) * | 2011-11-07 | 2014-12-08 | ザ ジェネラル ホスピタル コーポレイション | 赤血球の処理法 |
Also Published As
Publication number | Publication date |
---|---|
US5570683A (en) | 1996-11-05 |
DE69534755T2 (de) | 2006-11-16 |
DK0754069T3 (da) | 2004-11-01 |
ATE316396T1 (de) | 2006-02-15 |
DE69533190T2 (de) | 2005-08-18 |
EP0754069A1 (en) | 1997-01-22 |
ATE269731T1 (de) | 2004-07-15 |
EP1466641A1 (en) | 2004-10-13 |
CA2186892C (en) | 2007-11-27 |
EP0754069A4 (en) | 2000-01-19 |
KR100371082B1 (ko) | 2003-06-19 |
EP0754069B1 (en) | 2004-06-23 |
ES2224123T3 (es) | 2005-03-01 |
AU688027B2 (en) | 1998-03-05 |
EP1466641B1 (en) | 2006-01-25 |
DK1466641T3 (da) | 2006-05-29 |
WO1995026768A1 (en) | 1995-10-12 |
DE69533190D1 (de) | 2004-07-29 |
DE69534755D1 (de) | 2006-04-13 |
ES2255020T3 (es) | 2006-06-16 |
AU2205895A (en) | 1995-10-23 |
WO1995026768A9 (en) | 1999-10-21 |
CA2186892A1 (en) | 1995-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100371082B1 (ko) | 폐혈관수축및천식치료방법 | |
US5823180A (en) | Methods for treating pulmonary vasoconstriction and asthma | |
JP3718491B2 (ja) | 吸入用装置 | |
JP4652664B2 (ja) | Gsnoの充足を起こすガス状薬剤による肺疾患の処置 | |
Ichinose et al. | Selective pulmonary vasodilation induced by aerosolized zaprinast | |
US6592848B1 (en) | Mixtures of oxygen and helium for the treatment of respiratory insufficiency | |
Gelvez et al. | Effect of aerosolized milrinone during drug-induced pulmonary hypertension in lambs | |
Biney et al. | 13 Inhaled Therapy for Other Respiratory Diseases Pulmonary Hypertension | |
Matamis et al. | Free Papers | |
JPS59500900A (ja) | 薬剤の送出装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051213 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060310 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060508 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060612 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060808 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061206 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070119 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20070119 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20070308 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20070322 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20081111 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20081114 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20081212 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20081217 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090109 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090115 |